0000899243-19-010587.txt : 20190412
0000899243-19-010587.hdr.sgml : 20190412
20190412160029
ACCESSION NUMBER: 0000899243-19-010587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190411
FILED AS OF DATE: 20190412
DATE AS OF CHANGE: 20190412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 19746282
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-11
0
0001517022
Akebia Therapeutics, Inc.
AKBA
0001451805
Amello Jason
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP, CFO & Treasurer
Common Stock
2019-04-11
4
D
0
13148
7.70
D
118618
D
The proceeds from the disposition of these shares are to be used by the reporting person to cover tax liabilities associated with previously vested restricted stock units.
/s/ John P. Butler, Attorney-in-fact for Jason A. Amello
2019-04-12